Literature DB >> 19581055

Potential of vitamin E as an antioxidant adjunct in Wilson's disease.

Michael J Fryer1.   

Abstract

Wilson's disease is a rare genetic illness of copper metabolism, which leads to copper-overload in mitochondria and organ damage, especially to the liver. Oxidative stress is central to the pathogenesis and a case is briefly made for rigorous trials of vitamin E as an antioxidant adjunct based on earlier corollary studies of its levels in the blood and liver of Wilson's disease patients and its effects in animal models of the illness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19581055     DOI: 10.1016/j.mehy.2009.05.025

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  5 in total

1.  Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms.

Authors:  Radan Bruha; Libor Vitek; Zdenek Marecek; Lenka Pospisilova; Sona Nevsimalova; Pavel Martasek; Jaromir Petrtyl; Petr Urbanek; Alena Jiraskova; Ivana Malikova; Martin Haluzik; Peter Ferenci
Journal:  J Inherit Metab Dis       Date:  2011-12-03       Impact factor: 4.982

Review 2.  Inherited copper transport disorders: biochemical mechanisms, diagnosis, and treatment.

Authors:  Hiroko Kodama; Chie Fujisawa; Wattanaporn Bhadhprasit
Journal:  Curr Drug Metab       Date:  2012-03       Impact factor: 3.731

3.  Chemosensitivity of U251 Cells to the Co-treatment of D-Penicillamine and Copper: Possible Implications on Wilson Disease Patients.

Authors:  Meghri Katerji; Kassem Barada; Mustapha Jomaa; Firas Kobeissy; Ahmad-Kareem Makkawi; Wassim Abou-Kheir; Julnar Usta
Journal:  Front Mol Neurosci       Date:  2017-01-31       Impact factor: 5.639

4.  ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs.

Authors:  Cynthia R L Webster; Sharon A Center; John M Cullen; Dominique G Penninck; Keith P Richter; David C Twedt; Penny J Watson
Journal:  J Vet Intern Med       Date:  2019-03-07       Impact factor: 3.333

5.  Human Embryonic Stem Cell-Derived Wilson's Disease Model for Screening Drug Efficacy.

Authors:  Dongkyu Kim; Su-Bin Kim; Jung Lim Ryu; Heesu Hong; Jin-Hyuk Chang; Tack-Jin Yoo; Xiong Jin; Han-Jin Park; Choongseong Han; Beom Hee Lee; Jin-Ho Choi; Han-Wook Yoo; Jong-Hoon Kim; Dong-Hun Woo
Journal:  Cells       Date:  2020-04-02       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.